Provention Bio, Inc. Profile Avatar - Palmy Investing

Provention Bio, Inc.

Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and mon…

Biotechnology
US, Red Bank [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of PRVB's Analysis
CIK: 1695357 CUSIP: 74374N102 ISIN: US74374N1028 LEI: - UEI: -
Secondary Listings
PRVB has no secondary listings inside our databases.